Jeffrey Stein - Jun 9, 2022 Form 4 Insider Report for IDEAYA Biosciences, Inc. (IDYA)

Role
Director
Signature
/s/ Jason Throne, as Attorney-in-Fact for Jeffrey Stein
Stock symbol
IDYA
Transactions as of
Jun 9, 2022
Transactions value $
$0
Form type
4
Date filed
6/10/2022, 06:22 PM
Previous filing
Apr 4, 2022
Next filing
Feb 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDYA Stock Option (right to buy) Award $0 +11K $0.00 11K Jun 9, 2022 Common Stock 11K $12.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date.